Physician profile
Sunil Naik
NPI 1417116104
$6,104.48
in general payments reported to CMS, 2019-2025
29 companies · $1,550 in 2025
The $1,550 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $854 · 2020: $757 · 2021: $625 · 2022: $563 · 2023: $571 · 2024: $1,185 · 2025: $1,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,306.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,169.29 | 2019-2023 | Xarelto |
| Bard Peripheral Vascular, INC. | $540.16 | 2019-2021 | |
| Abiomed | $538.65 | 2019-2025 | Impella |
| Inari Medical, INC. | $506.98 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $481.79 | 2019-2025 | |
| Stryker Corporation | $437.06 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $361.76 | 2021-2025 | Corevalve Evolut R, Linq II, Emprint |
| Boston Scientific Corporation | $226.17 | 2019-2025 | General - Embolics, Embold Fibered, Icefx Cryoablation System |
| Pfizer INC. | $210.10 | 2020-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $192.19 | 2023-2025 | Lifevest |
| Amgen INC. | $191.77 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $187.88 | 2019-2020 | |
| Abbott Laboratories | $147.05 | 2019-2025 | Dragonfly Opstar, Optis, Pressurewire |
| Bolton Medical INC | $128.99 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Astrazeneca Pharmaceuticals LP | $111.85 | 2019-2024 | Farxiga, Brilinta |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $109.97 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $95.56 | 2022-2025 | Eliquis |
| Novo Nordisk INC | $79.63 | 2024-2025 | Rybelsus, Ozempic |
| Cook Medical LLC | $50.54 | 2019 | |
| Lantheus Medical Imaging, INC. | $49.02 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $47.31 | 2023-2024 | Optimizer, Optimizer |
| Cardiovascular Systems INC. | $46.30 | 2020 | |
| Merck Sharp & Dohme LLC | $41.61 | 2023-2024 | Verquvo |
| Edwards Lifesciences Corporation | $39.02 | 2020-2024 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $30.80 | 2022 | |
| Heartflow, INC. | $23.51 | 2021 | |
| Sirtex Medical INC | $22.12 | 2024 | Lava Les (Liquid Embolic System) |
| Terumo Medical Corporation | $21.47 | 2024 | Tr Band |
| Teleflex LLC | $15.93 | 2025 | Turnpike |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Naik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.